Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chiauranib”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Ended earlyNCT05336721
What this trial is testing

A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC

Who this might be right for
Triple-negative Breast Cancer
Chipscreen Biosciences, Ltd. 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06492915
What this trial is testing

Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Chipscreen Biosciences, Ltd. 42
Large-scale testing (Phase 3)Looking for participantsNCT04921527
What this trial is testing

Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerRelapsed or RefractoryChiauranib+1 more
Chipscreen Biosciences, Ltd. 454
Testing effectiveness (Phase 2)Study completedNCT05505825
What this trial is testing

AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
SCLC,Extensive Stage
Akeso 36
Not applicableStudy completedNCT05371899
What this trial is testing

Mass Balance Study of [14C]Chiauranib

Who this might be right for
Small Cell Lung Cancer
Chipscreen Biosciences, Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT05497843
What this trial is testing

Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)

Who this might be right for
Soft Tissue Sarcoma
Chipscreen Biosciences, Ltd. 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07445295
What this trial is testing

Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Chipscreen Biosciences, Ltd. 558
Testing effectiveness (Phase 2)Study completedNCT03974243
What this trial is testing

Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin's Lymphoma
Chipscreen Biosciences, Ltd. 9
Early research (Phase 1)Study completedNCT05346601
What this trial is testing

Trial of Chiauranib Capsule on Pharmacokinetics to Assess the Effect of High Fat Diet in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Chipscreen Biosciences, Ltd. 16
Early research (Phase 1)Study completedNCT02122809
What this trial is testing

Phase I Study of Chiauranib in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Chipscreen Biosciences, Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT03901118
What this trial is testing

Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Chipscreen Biosciences, Ltd. 47
Testing effectiveness (Phase 2)Study completedNCT03166891
What this trial is testing

Phase Ib Study of Chiauranib in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Chipscreen Biosciences, Ltd. 25
Large-scale testing (Phase 3)Study completedNCT04830813
What this trial is testing

Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Chipscreen Biosciences, Ltd. 184
Testing effectiveness (Phase 2)UnknownNCT05271292
What this trial is testing

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

Who this might be right for
Small Cell Lung CancerAdvanced Solid Malignant Tumor
Chipscreen Biosciences, Ltd. 36
Early research (Phase 1)Study completedNCT03216343
What this trial is testing

Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Chipscreen Biosciences, Ltd. 48
Early research (Phase 1)Ended earlyNCT03074825
What this trial is testing

Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Chipscreen Biosciences, Ltd. 5
Testing effectiveness (Phase 2)Study completedNCT03245190
What this trial is testing

Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chipscreen Biosciences, Ltd. 27